Of note, R-593 readily infected LNCaP cells, a human prostate cancer cell line, which naturally expresses PSMA (Figure 2G), implying that the extent of PSMA expression in human cancer cells makes them a target for R-593 infection and virotherapy. This evidence concerns the gene FOLH1 and prostate carcinoma.